What is the differential diagnosis and recommended workup for a patient with low serum albumin, elevated globulin, and a low albumin-to-globulin ratio?

Low Albumin with High Globulin and Low A/G Ratio: Differential Diagnosis and Workup

The most critical diagnosis to rule out immediately is multiple myeloma, which characteristically presents with this pattern and requires urgent evaluation with serum protein electrophoresis, immunofixation, serum free light chains, and bone marrow biopsy. 1, 2

Differential Diagnosis

The combination of low albumin, elevated globulin, and low A/G ratio creates a specific pattern that narrows your differential significantly:

Primary Considerations:

Multiple Myeloma - This is your highest priority diagnosis 1, 2, 3:

• Recent research demonstrates that A/G ratio has an AUC of 0.910 for diagnosing MM with 88.6% sensitivity 3
• The elevated globulin reflects monoclonal protein production
• Low albumin reflects both disease burden and inflammatory state
• This pattern is more specific for MM than for liver or kidney disease 3

Chronic Liver Disease 4:

• Globulin compensation occurs in 72.3% of hepatic disease cases when albumin drops
• However, the globulin elevation is typically less pronounced than in MM
• Look for stigmata of chronic liver disease, coagulopathy, and elevated transaminases

Chronic Infections/Inflammatory States:

• Tuberculosis (particularly with peritoneal involvement)
• HIV/AIDS
• Chronic bacterial infections
• Autoimmune conditions (SLE, rheumatoid arthritis)
• These cause polyclonal gammopathy rather than monoclonal

Nephrotic Syndrome 2:

• Primarily causes low albumin but typically with normal or low globulin
• Less likely to produce the high globulin pattern you're seeing

Recommended Workup Algorithm

Immediate First-Line Tests:

1. Serum protein electrophoresis (SPEP) with immunofixation 1, 2

   • Identifies monoclonal protein (M-spike)
   • Distinguishes monoclonal from polyclonal gammopathy

2. Serum free light chain (FLC) assay with kappa/lambda ratio 1, 2

   • Essential for diagnosis and has prognostic value
   • Required for documenting complete response
   • Useful even in oligosecretory or nonsecretory myeloma

3. 24-hour urine protein electrophoresis with immunofixation 1

   • 20% of MM patients have urinary M-proteins
   • Cannot be replaced by serum FLC assay for monitoring

4. Quantitative immunoglobulins (IgG, IgA, IgM) 1

   • Identifies which immunoglobulin is elevated
   • Helps characterize the monoclonal protein

Second-Line Tests Based on Initial Results:

If M-protein detected or high clinical suspicion for MM:

1. Complete blood count with differential 1, 2

   • Assess for anemia (Hgb <100 g/L or >20 g/L below normal)

2. Comprehensive metabolic panel 1, 2

   • Calcium (>2.75 mmol/L or >0.25 mmol/L above normal)
   • Creatinine and creatinine clearance (<40 mL/min)
   • BUN

3. Beta-2 microglobulin and LDH 1, 2

   • Prognostic markers reflecting tumor burden
   • Required for International Staging System

4. Skeletal survey or whole-body CT 2

   • Identify lytic bone lesions
   • CT is more sensitive than plain radiography

5. Bone marrow biopsy with FISH 1, 2

   • Confirms ≥10% clonal plasma cells
   • FISH identifies high-risk cytogenetics: t(4;14), del(17p), t(14;16)

If no M-protein but high globulin persists:

1. Liver function tests and hepatitis serologies

   • Evaluate for chronic liver disease

2. HIV testing, tuberculosis screening (QuantiFERON or PPD)

   • Rule out chronic infections

3. ANA, RF, complement levels

   • Screen for autoimmune conditions

Critical Pitfalls to Avoid

• Don't dismiss a normal SPEP alone - 3% of MM patients have nonsecretory disease 1. Always order serum FLC assay concurrently.

• Don't confuse polyclonal with monoclonal gammopathy - Immunofixation is essential to distinguish these. Chronic inflammation causes polyclonal elevation; MM causes monoclonal.

• Don't delay workup in asymptomatic patients - The 2014 IMWG criteria include biomarkers (≥60% plasma cells, FLC ratio >100, or MRI focal lesions) that define MM even without CRAB criteria 2. Early diagnosis matters.

• Don't forget that A/G ratio <0.9 has 88.6% sensitivity for MM 3 - This simple calculation should trigger immediate myeloma workup.

Interpretation Nuances

The A/G ratio performs better than individual albumin or globulin measurements for MM diagnosis (AUC 0.910 vs 0.865 and 0.909 respectively) 3. When differentiating MM from liver disease, both globulin and A/G ratio show high diagnostic value (AUC 0.881 and 0.884), but A/G ratio maintains the highest sensitivity 3.

In MM specifically, the low albumin reflects both the ISS staging system (albumin <3.5 g/dL defines higher stages) and overall prognosis 2. The elevated globulin directly represents the malignant monoclonal protein production.